Holen Sie sich die Stockscreener-App
47.50
2.56%
-1.25
Handel nachbörslich:
47.50
Finanzdaten der Revolution Medicines Inc-Aktie (RVMD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
9.95%
264.71
|
240.76 | 216.31 | 175.71 | 156.64 |
| Operating Income/Loss |
9.95%
-264.71
|
-240.76 | -216.31 | -175.71 | -156.64 |
| Nonoperating Income/Loss |
38.10%
16.93
|
27.34 | 20.99 | 19.42 | 23.41 |
| Income/Loss From Continuing Operations Before Tax |
16.11%
-247.79
|
-213.42 | -195.32 | -156.29 | -133.23 |
| Income/Loss From Continuing Operations After Tax |
16.11%
-247.79
|
-213.42 | -194.57 | -156.29 | -133.23 |
|
Net Income/Loss
|
16.11%
-247.79
|
-213.42 | -194.57 | -156.29 | -133.23 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.23%
188.58
|
188.15 | 2.1613 | 166.84 | 165.14 |
| Diluted Average Shares |
0.23%
188.58
|
188.15 | 2.1613 | 166.84 | 165.14 |
| Basic Earnings Per Share |
15.93%
-1.31
|
-1.13 | -1.13 | -0.94 | -0.81 |
| Diluted Earnings Per Share |
15.93%
-1.31
|
-1.13 | -1.13 | -0.94 | -0.81 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):